Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”
Joint Authors
Persad, Raj
Masson, Susan
Bahl, Amit
Source
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-1, 1 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-11-21
Country of Publication
Egypt
No. of Pages
1
Main Subjects
Abstract EN
In the article titled “HDR Brachytherapy in the Management of High-Risk Prostate Cancer” [1], there was an error in Table 2, which should be corrected as follows: For Hoskin et al.
[32], the dose should read 35.75 Gy in 13 fractions EBRT, not 55 Gy in 20 fractions EBRT.
American Psychological Association (APA)
Masson, Susan& Persad, Raj& Bahl, Amit. 2016. Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”. Advances in Urology،Vol. 2016, no. 2016, pp.1-1.
https://search.emarefa.net/detail/BIM-1096750
Modern Language Association (MLA)
Masson, Susan…[et al.]. Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”. Advances in Urology No. 2016 (2016), pp.1-1.
https://search.emarefa.net/detail/BIM-1096750
American Medical Association (AMA)
Masson, Susan& Persad, Raj& Bahl, Amit. Corrigendum to “HDR Brachytherapy in the Management of High-Risk Prostate Cancer”. Advances in Urology. 2016. Vol. 2016, no. 2016, pp.1-1.
https://search.emarefa.net/detail/BIM-1096750
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1096750
